Name: INTELLIA THERAPEUTICS INC (NTLA) Stock
Brand: INTELLIA THERAPEUTICS INC
Rating: 3.5 (3 reviews)

NTLA Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Chartmill - Mentions: OPEN GMED FOXF RUBI ...

Discover the top movers in Friday's pre-market session.

9 days ago - By: Chartmill

Intellia Therapeutics Inc (NASDAQ:NTLA) Plummets 24.5% After FDA Places Clinical Hold on Phase 3 Trials

10 hours ago - By: The Motley Fool - Mentions: SRPT

2 Beaten-Down Stocks to Avoid Right Now

a day ago - By: Zacks Investment Research - Mentions: REGN BEAM CRSP

Can NTLA Stock Bounce Back in 2026 After Recent Pipeline Setbacks?

3 days ago - By: Benzinga - Mentions: CSR BHF BBWI

This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday

5 days ago - By: Benzinga - Mentions: SPSC VAC

This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

5 days ago - By: Intellia Therapeutics, Inc.

Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Ziclumeran (nex-z) in Patients with Transthyretin (ATTR) Amyloidosis with Cardiomyopathy

5 days ago - By: Investor's Business Daily - Mentions: AAPL CRSP

Why Gene-Editing Giants Crispr And Intellia Just Surged

7 days ago - By: Intellia Therapeutics, Inc.

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

8 days ago - By: Bloomberg

Intellia Tumbles After Patient Dies Following Crispr Treatment

8 days ago - By: Zacks Investment Research - Mentions: REGN ANIP ACAD

Intellia Q3 Loss Narrower Than Expected, Stock Down on Pipeline Trouble

8 days ago - By: Investor's Business Daily - Mentions: RY RY.CA CRSP ALNY ...

Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies

8 days ago - By: The Motley Fool - Mentions: IOVA

2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street

9 days ago - By: Zacks Investment Research - Mentions: AGEN

Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates

9 days ago - By: Chartmill - Mentions: KRO CDXS GMED OLED ...

What's going on in today's after hours session

9 days ago - By: Intellia Therapeutics, Inc.

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates

10 days ago - By: Zacks Investment Research - Mentions: VRTX ANIP CRSP

VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve?

10 days ago - By: Zacks Investment Research - Mentions: ANIP MIRM ARQT

MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened

11 days ago - By: Zacks Investment Research - Mentions: VRTX ANIP CRSP

Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint

11 days ago - By: Zacks Investment Research - Mentions: JAZZ ANIP AXSM

AXSM Q3 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales

11 days ago - By: Zacks Investment Research - Mentions: TGTX ANIP ARQT

TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised

12 days ago - By: Zacks Investment Research - Mentions: VRTX BEAM CRSP

Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings?

15 days ago - By: Zacks Investment Research - Mentions: BEAM AGIO ANIP

AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues

15 days ago - By: Zacks Investment Research - Mentions: ANIP

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

17 days ago - By: Zacks Investment Research - Mentions: EBS

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates

17 days ago - By: Chartmill - Mentions: FMC EBS WOLF CMG ...

What's going on in today's after hours session

19 days ago - By: Chartmill - Mentions: IRBT PRE DYN SOHO ...

Which stocks are moving on Monday?

19 days ago - By: Chartmill - Mentions: IRBT GGAL BMA DYN ...

Keep an eye on the top gainers and losers in Monday's session.

19 days ago - By: Chartmill - Mentions: IRBT GGAL BMA UAMY ...

Which stocks are gapping on Monday?

19 days ago - By: Chartmill - Mentions: GGAL BMA PRE SOHO ...

INTELLIA THERAPEUTICS INC (NTLA) Stock News

NTLA Latest News, Press Relases and Analysis

Discover the top movers in Friday's pre-market session.

Intellia Therapeutics Inc (NASDAQ:NTLA) Plummets 24.5% After FDA Places Clinical Hold on Phase 3 Trials

2 Beaten-Down Stocks to Avoid Right Now

Can NTLA Stock Bounce Back in 2026 After Recent Pipeline Setbacks?

This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday

This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Ziclumeran (nex-z) in Patients with Transthyretin (ATTR) Amyloidosis with Cardiomyopathy

Why Gene-Editing Giants Crispr And Intellia Just Surged

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

Intellia Tumbles After Patient Dies Following Crispr Treatment

Intellia Q3 Loss Narrower Than Expected, Stock Down on Pipeline Trouble

Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies

2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street

Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates

What's going on in today's after hours session

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates

VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve?

MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened

Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint

AXSM Q3 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales

TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised

Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings?

AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates

What's going on in today's after hours session

Which stocks are moving on Monday?

Keep an eye on the top gainers and losers in Monday's session.

Which stocks are gapping on Monday?

These stocks are moving in today's pre-market session